At the same time, Xiyanping injection inhibits the release of a variety of inflammatory factors by inhibiting intracellular MAPK, TNF, and other pathways and inhibiting NF-κB and other pathways in the nucleus, thus playing a role in the treatment of COVID-19. The gene discussed is NFKB1; the disease is COVID-19.